Testing higher-dose proton radiation for new glioblastoma
Part of Cancer clinical trials.
This trial is testing an escalated dose of proton beam radiation, along with standard chemotherapy and MRI-guided planning, for newly diagnosed glioblastoma. It aims to see whether the higher radiation dose can improve treatment while staying safe for nearby critical brain structures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have newly diagnosed glioblastoma with scans showing contrast-enhancing tumor, and an IDH-wildtype result
- Your care team believes it’s safe to treat you with planned 60 Gy chemoradiation (radiation plus chemotherapy)
- Your MRI shows at least 5 millimeters of space between the tumor and key “protected” structures like the brainstem or optic nerves/chiasm
- You are 18 years or older, and your daily functioning is at least fair (Karnofsky score 70 or higher)
- Your blood tests are high enough for chemotherapy, as your doctor confirms
- You can safely have MRI scans and receive contrast dye (gadolinium) if needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of giving radiation—standard photon radiotherapy (IMRT) versus proton beam therapy—for people with glioblastoma. It may help find a safer or more effective radiation approach for shrinking tumors and improving outcomes.
This trial tests a shorter, more intense course of radiation therapy (hypofractionated radiotherapy) for people with newly diagnosed glioblastoma who have had surgery. The goal is to see if this approach is safe and works well for treating the tumor.
This trial studies different treatment regimens for people with glioblastoma that is either newly diagnosed or has come back. It aims to find which treatment approach works best for controlling the tumor and improving outcomes.
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
This trial tests a new type of targeted radiation therapy for people with high-grade glioma (grade 3 or 4) that has not progressed after standard treatment. The therapy uses a radioactive substance attached to a protein that targets tumor cells, aiming to deliver radiation directly to the cancer.
This trial tests a more intense chemotherapy plan for people with glioblastoma who had only partial removal of their tumor or whose tumor grew back quickly. The goal is to see if this approach can improve outcomes.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.